The speaker Dr. Richard Ablin discovered the PSA value in 1970 and is now reflecting critically on its use for prostate cancer screening.

Moderation:

Prof. Dr. Ulrich Dirnagl
Founding Director of QUEST The Center for Transforming Biomedical
Research, Berlin Institute of Health

Panel discussion:

Prof. Gerd Gigerenzer
Director at the Max Planck Institute for Human Development, Director of the Harding Center for Risk Literacy in Berlin

Prof. Dr. Dr. Tobias Kurth
Director of the Institute of Public Health
Charité – Universitätsmedizin Berlin

Prof. Dr. med. Carsten Stephan
Clinic for Urology
Charité Universitätsmedizin Berlin




Timestamps:
__________________________________________________
24:33 Overdiagnosis and Overtreatment
01:11:49 DISCUSSION
__________________________________________________